Virax Biolabs Group Stock Market Capitalization
| VRAX Stock | USD 2.01 0.07 3.61% |
Virax Biolabs Group fundamentals help investors to digest information that contributes to Virax Biolabs' financial success or failures. It also enables traders to predict the movement of Virax Stock. The fundamental analysis module provides a way to measure Virax Biolabs' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Virax Biolabs stock.
| Last Reported | Projected for Next Year | ||
| Market Cap | 1.5 M | 1.4 M |
Virax | Market Capitalization |
Virax Biolabs Group Company Market Capitalization Analysis
Virax Biolabs' Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current Virax Biolabs Market Capitalization | 8.73 M |
Most of Virax Biolabs' fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Virax Biolabs Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Virax Market Capitalization Driver Correlations
Understanding the fundamental principles of building solid financial models for Virax Biolabs is extremely important. It helps to project a fair market value of Virax Stock properly, considering its historical fundamentals such as Market Capitalization. Since Virax Biolabs' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Virax Biolabs' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Virax Biolabs' interrelated accounts and indicators.
Click cells to compare fundamentals
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
| Competition |
Based on the recorded statements, the market capitalization of Virax Biolabs Group is about 8.73 M. This is 99.93% lower than that of the Biotechnology sector and 99.82% lower than that of the Health Care industry. The market capitalization for all United States stocks is 99.95% higher than that of the company.
Virax Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Virax Biolabs' direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Virax Biolabs could also be used in its relative valuation, which is a method of valuing Virax Biolabs by comparing valuation metrics of similar companies.Virax Biolabs is currently under evaluation in market capitalization category among its peers.
Virax Biolabs ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Virax Biolabs' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Virax Biolabs' managers, analysts, and investors.Environmental | Governance | Social |
Virax Fundamentals
| Return On Equity | -0.96 | ||||
| Return On Asset | -0.5 | ||||
| Operating Margin | (42.54) % | ||||
| Current Valuation | 5.36 M | ||||
| Shares Outstanding | 4.34 M | ||||
| Shares Owned By Insiders | 7.06 % | ||||
| Shares Owned By Institutions | 5.37 % | ||||
| Number Of Shares Shorted | 446.54 K | ||||
| Price To Book | 1.63 X | ||||
| Price To Sales | 55.79 X | ||||
| Revenue | 156.42 K | ||||
| Gross Profit | (1.36 K) | ||||
| EBITDA | (6.61 M) | ||||
| Net Income | (6.74 M) | ||||
| Cash And Equivalents | 21.76 K | ||||
| Total Debt | 224.3 K | ||||
| Current Ratio | 0.04 X | ||||
| Book Value Per Share | 2.08 X | ||||
| Cash Flow From Operations | (6.25 M) | ||||
| Short Ratio | 0.11 X | ||||
| Earnings Per Share | (3.36) X | ||||
| Target Price | 20.0 | ||||
| Number Of Employees | 17 | ||||
| Beta | 1.93 | ||||
| Market Capitalization | 8.73 M | ||||
| Total Asset | 5.48 M | ||||
| Retained Earnings | (18.53 M) | ||||
| Working Capital | 4.21 M | ||||
| Net Asset | 5.48 M |
About Virax Biolabs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Virax Biolabs Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Virax Biolabs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Virax Biolabs Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Virax Stock Analysis
When running Virax Biolabs' price analysis, check to measure Virax Biolabs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virax Biolabs is operating at the current time. Most of Virax Biolabs' value examination focuses on studying past and present price action to predict the probability of Virax Biolabs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virax Biolabs' price. Additionally, you may evaluate how the addition of Virax Biolabs to your portfolios can decrease your overall portfolio volatility.